MedPath

Anatomical and Functional Outcome of PSG Vs BMG for Urethral Substitution in Long Segment Anterior Urethral Strictures

Not Applicable
Recruiting
Conditions
Anterior Urethral Stricture, Male
Registration Number
NCT06056856
Lead Sponsor
Al-Azhar University
Brief Summary

This study aims to compare the penile skin graft and buccal mucosal graft for substitution of long anterior urethral strictures using one-sided dorsal perineal approach.

Detailed Description

Since previous studies were:

* Retrospective and very few were prospective randomized studies

* Some studies were done on lichen sclerosis cases that have an adverse effect on the PSG outcome.

* The follow-up duration was longer for PSG patients.

* Stricture length was usually longer for PSG cases.

This study aims to compare the PSG and BMG for substitution of long anterior urethral strictures using one-sided dorsal perineal approach.

The investigators hypothesize that:

❶ Conducting a well-designed prospective, randomized study can help identify which technique is better than the other.

❷ Using the one-side dorsal approach can improve the outcomes of both techniques and identify their advantages and disadvantages.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • The study will include patients with long segment anterior urethral stricture (>2 cm).
Exclusion Criteria
  • Urethro-cutaneous fistula, urethral abscess or diverticulum.
  • A scarred and unsalvageable urethral plate or scarred perineum.
  • Lichen sclerosis (Balanitis xerotica obliterans).
  • Unhealthy/unavailable buccal mucosa.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The degree of urethral lumen patency.through study completion, an average of 1 year.

Patent urethra as evidenced by uroflowmetry and retrograde urethrography +/- urethroscopy

Secondary Outcome Measures
NameTimeMethod
Lower urinary tract symptoms improvement6 months

lower urinary tract symptoms as assessed by the international prostate symptom score, ranging from 0 to 35, where scores from 0-7 are mild, from 8-19 are moderate, from 20-35 are severe symptoms.

Erectile function assessment6 months

sexual function as assessed by the international index of erectile function-5 questionnaire, ranging from 5-25, where 22-25 is normal, 17-21 is mild ED, 12-16 is mild to moderate ED, 8-11 is moderate ED, and 5-7 is severe ED.

Trial Locations

Locations (1)

Al-Azhar urology department, Al-Azhar university hospitals

🇪🇬

Cairo, Egypt

Al-Azhar urology department, Al-Azhar university hospitals
🇪🇬Cairo, Egypt
Malakah Mohamed, secretary
Contact
+20225107222
urologydepartment@azhar.edu.eg
Samah Adel, secretary
Contact
00201007561116

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.